Abstract Trisomy 21 or Down syndrome (DS) is the most common cause of intellectual disability of a genetic origin. The Ts65Dn (TS) mouse, which is the most commonly used and best-characterized mouse model of DS, displays many of the cognitive, neuromorphological, and biochemical anomalies that are found in the human condition. One of the mechanisms that have been proposed to be responsible for the cognitive deficits in this mouse model is impaired GABAmediated inhibition. Because of the well-known modulatory role of GABA A α5 subunit-containing receptors in cognitive processes, these receptors are considered to be potential targets for improving the intellectual disability in DS. The chronic administration of GABA A α5-negative allosteric modulators has been shown to be procognitive without anxiogenic or proconvulsant side effects. In the present study, we use a genetic approach to evaluate the contribution of GABA A α5 subunit-containing receptors to the cognitive, electrophysiological, and neuromorphological deficits in TS mice. We show that reducing the expression of GABA A α5 receptors by deleting one or two copies of the Gabra5 gene in TS mice partially ameliorated the cognitive impairments, improved longterm potentiation, enhanced neural differentiation and maturation, and normalized the density of the GABAergic synapse markers. Reducing the gene dosage of Gabra5 in TS mice did not induce motor alterations and anxiety or affect the viability of the mice. Our results provide further evidence of the role of GABA A α5 receptor-mediated inhibition in cognitive impairment in the TS mouse model of DS.
Introduction
It is well established that the GABA A receptor plays an important role in learning and memory processes. Non-selective positive allosteric modulators (PAMs) of the GABA A receptor, such as benzodiazepines, disrupt learning, and memory processes [1] [2] [3] , while non-selective antagonists and negative allosteric modulators (NAMs) improve cognitive processes [4] [5] [6] [7] . In addition, non-selective GABA A NAMs, such as DMCM, increase long-term potentiation (LTP) [8] , whereas non-selective GABA A positive allosteric modulators (PAMs) (e.g., diazepam) impair LTP [9] .
Among the different GABA A receptor subtypes, the GABA A α5 subunit-containing receptors, which are predominantly expressed in the hippocampus [10] [11] [12] [13] , are mainly localized extrasynaptically and generate long-lasting tonic Electronic supplementary material The online version of this article (doi:10.1007/s12035-017-0675-3) contains supplementary material, which is available to authorized users.
currents [14] [15] [16] [17] . These receptors have been demonstrated to play an important modulatory role in learning and memory processes.
Studies have demonstrated that homozygous (−/−) knockout mice lacking the Gabra5 gene show an improvement in cognitive processes [18, 19] , thereby providing genetic evidence supporting that this receptor subtype plays a role in cognition. In addition, α5(H105R) knock-in mice showed a decreased expression of the GABA A α5 receptor in the hippocampus, which induced an enhancement in hippocampus-dependent learning and memory [20] and fear conditioning [21] . These findings, together with the restricted expression pattern of the GABA A α5 receptors, make these receptors attractive targets for the pharmacological enhancement of learning and memory [22, 23] . Several GABA A α5 NAMs, including L-655708, α5IA, MRK-016, and RO4938581, have been shown to improve learning and memory in preclinical studies [22, 24, 25] . In addition, α5IA was shown to restore ethanol-induced cognitive impairments in healthy volunteers [26] .
Down syndrome (DS) is the most common cause of an intellectual disability of a genetic origin [27, 28] . To understand the neurobiological basis of the cognitive impairments found in DS and develop therapeutic strategies to reduce these alterations, several murine models of DS have been developed. Among these models is the Ts65Dn (TS) mouse, which bears a partial trisomy of a segment of MMU16, which extends from the Mrp139 to the Znf295 genes and contains approximately 92 genes that are orthologous to the human chromosome 21 (HSA21) genes [29] . Additionally, TS mice carry a trisomy of~10 Mb of MMU17 containing 60 genes that are non-homologous to HSA21 [30, 31] ; thus, these genes are not relevant to DS and may confound phenotypic consequences. Although the TS mouse is not the ideal model from a genetic point of view, it recapitulates many fundamental features of DS, including cognitive deficits and alterations in brain morphology and function [32] [33] [34] . Several other segmental trisomic models of different segments of MMU16, 17, and 10 have been created [see 31, 32, 34] . A comparison of phenotypes in TS mice with those of other partial trisomic models suggests that the set of genes triplicated in this model contributes to several DS phenotypes, including cognitive and neuroanatomical impairments [34] . For these reasons, most previous studies on DS structural and functional alterations have been performed on the TS mouse.
Although many of the neuromorphological alterations that are present in the TS mouse are likely partially responsible for their cognitive deficits, including the changes in the size, morphology, and cellular density of different brain areas and the alterations in pre-and postnatal neurogenesis, dendritic structures, and the morphology of synapses and spines [see 32, 34] , abnormal synaptic plasticity (reduced hippocampal LTP and increased LTD) has been proposed to be a key mechanism underlying the intellectual disabilities in TS mice [35] [36] [37] .
In addition, several studies have demonstrated that in this murine model of DS, there is altered synaptic inhibition, which is mediated by the GABA A receptor [36] [37] [38] [39] [40] . The administration of non-selective GABA A antagonists to TS mice rescued the deficits in LTP and the hippocampal-mediated memory impairments in the TS mice [41] [42] [43] . However, these drugs are not adequate candidates for the treatment of learning impairments in the DS population due to their anxiogenic and proconvulsant effects.
The identification of the different functional roles of GABA A receptor subtypes suggests that receptor subtypeselective compounds could overcome the limitations of non-selective GABA A receptor modulators. The administration of the α5-selective NAMs α5IA and RO4938581 rescued the cognitive deficits in TS mice [44, 45] . In addition, the chronic administration of RO4938581 rescued the deficits in hippocampal synaptic plasticity, enhanced neurogenesis in the dentate gyrus and the granular cell density, and normalized the density of hippocampal GABAergic boutons in TS mice [40, 45] . Importantly, none of these compounds are proconvulsant or anxiogenic [40] .
Although Gabra5, which is the gene that encodes the α5 subunit of the GABA A receptor, is not localized in HSA21 or in the segment of MMU16 that is triplicated in the TS mouse and there is no evidence of alterations in the density of this type of receptor in this model of DS [40, 45] , the impaired GABA-mediated inhibition could be mediated via the GABA A α5 subtype, which is abundant in the hippocampus. To test this hypothesis, in this study, we used a genetic approach to specifically reduce the inhibition that is mediated by these receptors in the TS mouse by deleting one or two copies of the Gabra5 gene. We crossed female TS and euploid (control, CO) mice with male Gabra5 knockout mice and performed a behavioral, electrophysiological, and neuromorphological characterization of the progeny (TS and CO mice carrying 2, 1, or 0 functional copies of the Gabra5 gene).
Material and Methods

Animals
Ts(17<16>)65Dn (TS) mice were generated by repeated backcrossing of B6EiC3Sn a/A-Ts(17<16>)65Dn females with C57BL/6Ei × C3H/HeSNJ (B6EiC3Sn) F1 hybrid (CO) males at the animal facilities of the University of Cantabria.
Because the Gabra5 (α5 subunit of the GABA A receptor) gene is located in MMU7 and its orthologous human gene is located in HSA15, the TS progenitors carry two alleles of this gene. TS females were crossed with heterozygous males carrying a mutated copy of the Gabra5 gene (see Fig. 1a ). Gabra5 KO mice were generated as previously described (gl-α5-KO, Rodgers et al. [48] ) and provided by F. Hoffmann-La Roche Ltd. (Basel, Switzerland).
From these crossings, a first generation (F1) was obtained, including the following four mouse genotypes: TS with two copies of Gabra5 (TS +/+), TS with a single functional copy of Gabra5 (TS +/−), CO with two copies of Gabra5 (CO +/+), and CO mice with a single functional copy of Gabra5 (CO +/−).
Female TS +/− mice were then crossed with male CO +/− mice to obtain TS and CO mice (F2) with two functional copies, one functional copy, or no functional copies of Gabra5 (i.e., TS +/+, CO +/+, TS +/−, CO +/−, TS −/−, and CO −/− mice; see Fig. 1a ).
To determine the presence of the trisomy, animals were karyotyped using real-time quantitative PCR (qPCR) as previously described [46] . Because the C3H/HeSnJ mice carry a recessive mutation that leads to retinal degeneration (Rd) [47] , all animals were genotyped by standard PCR to screen for mice carrying this gene.
To determine the number of functional copies of the Gabra5 gene carried by each animal, their genomic DNA was amplified by standard PCR following the protocol described by Rodgers et al. [48] .
Mice were housed in groups of two or three in clear Plexiglas cages (20 × 22 × 20 cm) under standard laboratory conditions with a temperature of 22 ± 2°C, 12-h light/dark cycle and free access to food and water. The light/dark cycle was inverted to allow for the behavioral studies to be conducted during the active period of the mice.
In this study, two cohorts of male mice were used (see Supplementary Table 1 determine the effect of the gene dosage of Gabra5 on cognition, behavior, and neuromorphology in the TS and CO mice. The second cohort of animals was used to assess the GABA A α5 receptor density in the different Gabra5 genotype groups by autoradiography.
The behavioral experiments were performed with a total of 66 4-to 5-month-old mice (8-13 animals per group; see Supplementary Table 1) . After the completion of these studies, the mice were sacrificed at the age of 5-6 months; six animals from each group were used for the histological experiments. In addition, seven 6-month-old animals per group were used for the autoradiography experiments (two to seven animals per group). The researchers were blinded to the genotype and karyotype throughout the entire assessment.
Viability of the Different Groups of Mice and Somatometry
The viability of the different groups of mice born from the crossings of female TS +/− and male CO +/− mice was assessed by quantifying the number of animals with each karyotype and genotype born in each litter. In total, 100 male mice, born in 28 litters, were analyzed.
The effect of the karyotype and the genotype on the weight of the animals was evaluated once a month from weaning to the age of 5 months in 10 mice from each experimental group.
Quantification of GABA A α5 Receptors: In Vitro Autoradiography
To evaluate whether the gene dosage of Gabra5 led to changes in the number of GABA A α5 receptors, the occupancy of GABA A α5 receptors was quantified using a specific radioligand.
Mice were sacrificed by cervical dislocation, and their brains were rapidly removed and stored at −20°C. The brains were subsequently cut into 10 μm-thick coronal sections with a cryostat and mounted on HistoBond glass slides (Marienfeld, Lauda-Königshofen, Germany).
To perform the autoradiographic marking, a tritiated radioligand with a high affinity for GABA A α5 receptors, Hoffmann-La Roche, Basel, Switzerland), was used following the protocol described by Sur et al. [49] .
The slides were preincubated in a Ringer buffer with a pH of 7.4 (Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 20 min, followed by an incubation with 0.94 μl of [ 3 H] RO 15-4513 (specific activity 47.2 Ci/mmol) in 400 ml of the Ringer buffer (pH 7.4) for 1 h. This procedure was performed in duplicate for each animal. Non-specific binding was defined in a single sample per mouse under the same conditions described previously, but 10 μM of flunitrazepam (Sigma-Aldrich) was added. The slides were then washed twice for 2 min in the Ringer buffer at 4°C, followed by four immersions of the samples in distilled water at 4°C. The samples were dried by a cold air current for 3 h, and they were then exposed to tritium sensitive photographic films (Biomax MR Kodak, Madrid, Spain) for 3 months at 4°C in hermetic imaging plates (Kodak X-Omatic cassette™, USA).
The autoradiograms were scanned and quantified by optical densitometry using the image analysis software Scion Image (Scion Corporation, MD, USA 
Cognitive Studies
Morris Water Maze
The Morris Water Maze test was performed to evaluate spatial learning using the platform relocation protocol [50] [51] [52] [53] that was described by Corrales et al. [54] . Briefly, the animals were tested in 12 consecutive daily sessions consisting of eight acquisition sessions (platform submerged), followed by four cued sessions (platform visible). Each session consisted of eight trials, and the platform position was changed from session to session. Each trial terminated when the mouse located the platform or 60 s had elapsed. All trials were videotaped with a camera located 2 m above the water level. An AnyMaze computerized tracking system (Stoelting, Wood Dale, IL, USA) was used to analyze the swimming trajectories, escape latency, thigmotaxis, and swimming speed of each animal in each trial.
Fear Conditioning
The fear conditioning experiment procedure was performed as described by Salehi et al. [55] . Briefly, contextual and tonecued fear conditioning tests were performed using the Fear Conditioning apparatus (Stoelting) and the AnyMaze Video Tracking System (Stoelting). The mice underwent 3 days of testing as follows: a training day, a tone-cued in a novel context testing day, and a contextual testing day. On the first day, the mice underwent a training session in which each mouse received five tone (70 dB, 2 kHz, 20 s)-shock (0.5 mA, 50 Hz, 2 s) pairings. On the second day, each mouse was placed in a novel context for 3 min and was presented with three tone exposures without any shocks. On the final day, each mouse was placed in a context that was similar to that in the training day for 5 min without any tones or shocks. The freezing behavior of the mice in each condition was quantified on both testing days.
Histological and Stereological Procedures
The animals were deeply anesthetized with pentobarbital (50 mg/kg) and transcardially perfused with saline, followed by 4% paraformaldehyde. Subsequently, the brains were postfixed in 4% paraformaldehyde overnight at 4°C and transferred to 30% sucrose. The brains were frozen on dry ice and coronally sliced with a cryostat (50-μm thick sections). Series of brain slices, comprising one section for every nine slices, were used for the immunohistochemistry protocol. A one-in-nine series of coronal sections was randomly selected and subjected to Nissl staining using the Cavalieri method, as previously described [56] , to calculate the subgranular zone (SGZ) area and the dentate gyrus (DG) volume.
Density of GABAergic Synapse Markers (VGAT Immunofluorescence)
One-in-nine serial 50-μm sections of the mice brains were used to determine the density of a GABAergic synapse marker. The sections were preincubated in PBT/BSA, and dual immunohistochemistry was performed. The GABAergic boutons were labeled using a goat anti-GABA vesicular transporter antibody (VGAT, 1:100; Santa Cruz Biotechnology, Dallas, TX, USA), followed by additional labeling with a donkey anti-goat Alexa Fluor® 594-conjugated antibody (1:1000; Invitrogen, Carlsbad, CA, USA).
Measurements were performed on images obtained using a confocal microscope (Leica SP5). Four sections per animal were used, which constituted the entire hippocampus, and one random area in the hippocampus per section was measured. The image analysis was performed using the ImageJ software as previously described [45] , and the percentage of the reference area that was occupied by VGAT-positive boutons was calculated.
VGAT-positive boutons were quantified in the DG inner molecular layer (IML) (Fig. 1b) . This area was chosen because it contains an important inhibitory microcircuit that participates in the modulation of the activity of the DG [57, 58] . In this zone, a large number of inhibitory synapses are established between axons from the commissural/ associational pathway and the dendrites of proximal granular cells [59, 60] . In addition, the IML is likely the most plastic zone of the ML because it is the first area where the dendritic trees of newborn neurons arrive after neural maturation during adult neurogenesis [61] . The IML is also the only stratum to which the dendritic trees of some of these immature neurons arrive, as after performing their functions, they occasionally do not differentiate further and instead die. Therefore, the IML is an adequate area in which to evaluate inhibitory drive and changes in plasticity that can affect cognitive processes.
Cell Proliferation in the SGZ of the DG (Ki67 Immunofluorescence)
Ki67 immunofluorescence was performed to identify proliferating cells. The sections were preincubated in PBT/BSA (PB containing 0.5% Triton X-100 and 0.1% BSA), and immunohistochemistry was performed as previously described [56] . Briefly, free-floating sections were incubated with a primary rabbit anti-Ki67 antibody (1:750; Abcam, Cambridge, UK) for 2 days at 4°C. Subsequently, the slices were incubated overnight at 4°C with a secondary antibody diluted to 1:1000 (donkey anti-rabbit-Alexa Fluor® 488; Molecular Probes, Eugene, OR, USA). The sections were counterstained with DAPI and mounted on gelatin-covered slides for the analysis and imaging. The total number of Ki67-positive cells was counted under an optical fluorescence microscope (Zeiss Axioskop 2 Plus, 40× objective) using the optical dissector method as previously described [56] .
Neuronal Differentiation (DCX and CLR Immunofluorescence) Doublecortin (DCX) is a microtubule-associated protein implicated in neural differentiation and migration, and calretinin (CLR) is a calcium binding protein that is briefly expressed before full neuronal maturation. Double labeling of these cells allows the identification of different neurogenic populations: DCX+/CLR− cells correspond to 2b and 3 neurogenic precursors (i.e., cells undergoing late mitosis or in early postmitotic phases), while DCX+/CLR+ cells are late postmitotic differentiating cells [62, 63] .
One-in-nine series of 50-μm sections were used for the determination of the densities of the cells expressing immature markers (DCX and/or CLR). The sections were initially preincubated in PBT/BSA, and dual immunohistochemistry was subsequently performed. A goat anti-doublecortin antibody (1:250; Santa Cruz Biotechnology) and a rabbit anticalretinin antibody (1:3000; Swant, Switzerland) were used as the primary antibodies. The primary antibodies were labeled with a donkey anti-goat Alexa Fluor® 594-conjugated antibody and a donkey anti-rabbit Alexa Fluor® 488-conjugated antibody (1:1000; Alexa Fluor®-conjugated antibodies purchased from Invitrogen, Carlsbad, CA, USA). The sections were subsequently imaged under a confocal microscope (Leica SP5). The quantification of the DCX-and CLR-expressing cells was performed according to stereological procedures using the physical dissector method. To evaluate the cells expressing the immature markers, six random dissectors per animal were used, comprising sections representative of the entire hippocampus. A series of 11 confocal images was serially recorded in each physical dissector. All immature cells were counted using the physical dissector, which has a square area with one side that lies on the Blineô f the SGZ (Fig. 1b) . By dividing the number of counted immature cells by the length of the Bsubgranular^line, a reliable estimate of the cell density by Bunit of SGZ^was obtained. The cell density of the immature neurons is presented as either DCX+ (DCX+/CLR-) or CLR+ (DCX+/CLR+ plus DCX−/CLR+).
Granule Cell Counts (DAPI)
The cells in the hippocampal granule cell layer (GCL; Fig. 1b) were counted in sections stained with 4′6-diamidino-2-phenylindole (DAPI, Calbiochem, Billerica, MA, USA; 1:1000) for 10 min in phosphate buffer (PB). The cell counts were obtained using a confocal microscope coupled to a physical dissector system as previously described [56] . Six dissector locations in each series were evaluated. Subsequently, a series of confocal images was serially recorded according to the general principles of the physical dissector and the unbiased stereology methods. The confocal images were analyzed using the ImageJ software which generated the total number of cells when the dissector brick was completed. To count the total number of cells in the GCL, a square dissector frame was randomly situated inside the GCL. To obtain the number of cells per unit of volume (cell density), the obtained cell number was divided by the reference volume of the dissector.
Long-Term Potentiation
LTP recordings were performed in the CA1/CA3 region (Fig.  1b) because GABA A α5 receptors are mainly localized to the extrasynaptic regions of the dendrites of pyramidal neurons of the hippocampal CA1 and CA3 regions, where they mediate tonic inhibition [15, 20, 64, 65] .
Due to the low viability of the TS −/− animals ( Fig. 1c) , it was not possible to obtain the necessary number of mice to perform this experiment, and LTP was not assessed in this group. Six 6-month-old animals were used in each of the other experimental groups (TS +/+, TS +/−, CO +/+, CO +/−, CO −/−). The mice were decapitated, and the brains were rapidly removed. The hippocampi were dissected, and 400-μm slices were generated using a tissue chopper. The slices were allowed to recover for 1 h in an interface chamber at room temperature in artificial cerebral spinal fluid (ACSF) containing 120 mM NaCl, 3.5 mM KCl, 2.5 mM CaCl 2 , 1.3 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , and 10 mM D-glucose saturated with 95% O 2 and 5% CO 2 . The field excitatory postsynaptic potentials (fEPSPs) were recorded from the CA1 stratum radiatum using a glass micropipette (1-4 MΩ) containing 2 M NaCl, and the Schaffer collaterals were stimulated using insulated bipolar platinum/iridium electrodes located >500 μm from the recording electrode. The stimulus strength was adjusted to evoke fEPSPs equal to 50% of the relative maximum amplitude without a superimposed population spike. After the stable baseline recordings (100-μs pulse duration, 0.033 Hz), long-term potentiation (LTP) was induced by TBS (10 trains of 5 pulses at 100 Hz and intervals of 200 ms). The duration of the stimulation pulses was doubled during tetanus. The fEPSPs were amplified, bandpass filtered (1 Hz-1 kHz) and stored in a computer using the Spike2 software program (Cambridge Electronic Design, Cambridge, UK). For the analysis, the fEPSP slopes were expressed as a percentage of the recorded baseline values. The results from several slices were expressed as the mean value ± SEM.
Statistical Analysis
The data obtained from the Morris water maze (MWM) test experiments were analyzed using a two-way repeated measures ANOVA (RM MANOVA) (Bsession × karyotype × genotype^or Btrial × karyotype × genotype^). The LTP data were analyzed using RM MANOVA (Btime × karyotype × genotype^).The remaining data were analyzed using a two-way (Bkaryotype^× Bgenotype^) ANOVA. The mean values of each experimental group were compared post hoc using Bonferroni tests. The percentage of animals born in each experimental group (viability study) was analyzed using chi-squared tests. All analyses were performed using SPSS for Windows version 22.0. (Armonk, New York, USA).
Results
Viability
The number of animals born with each genotype significantly differed (χ 2 (d.f. = 5) = 20.26, p = 0.0011; Fig. 1c ) from the predicted Mendelian distribution (12.5% for the CO +/+, TS +/+, CO −/− and TS −/− animals and 25% for the CO +/− mice and TS +/− mice). Although the +/− animals doubled the percentage of the +/+ and −/− mice in both genotypes, the TS mice carrying the different gene dosages of the Gabra5 gene showed a marked reduced viability as has been previously demonstrated in numerous studies. In addition, while the percentage of animals with the CO +/+ genotype did not differ from that of the CO −/− animals (in both cases, they represented 50% of the number of the CO +/− animals (χ 2 (d.f. = 2) = 0.16, p = 0.91)), the TS −/− animals showed a reduced viability (only approximately 3% of the animals born belonged to this genotype and karyotype) from that expected, although this effect did not reach statistical significance (χ 2 (d.f. = 2) = 0.84, p = 0.65). Therefore, the karyotype, but not the genotype, affected the viability of the mice.
Effects of Reducing Gabra5 Dosage on Cognitive Performance
MWM
Consistently with numerous reports, the TS mice had more difficulties in learning the platform position than the CO mice as they displayed larger latencies to escape from the MWM than the CO mice (ANOVA karyotype F (1,60) = 105.28, p < 0.001; Fig. 2a ). The reduction in the Gabra5 gene dosage had a significant effect in both the TS and CO mice; however, this effect was more evident in the TS mice (ANOVA genotype F (2,60) = 6.89, p = 0.002; Bgenotype × treatmentF (2,60) = 2.80, p = 0.069). The TS mice that had a single functional copy of this gene showed an improved performance compared with mice that had both copies, and this improvement was more evident in the TS animals without any functional copy of this gene. In the case of the CO mice, both groups of KO mice displayed a slight improvement in their performance in this test compared with the CO +/+ animals; however, no differences were evident between the CO +/− and the CO −/− groups. It is possible that a floor effect prevented further improvements in the CO −/− group.
These improvements in the performance in the MWM may be partially due to a recovery in their procedural learning. Figure 2b shows the time that the animals spent in the periphery of the pool. Reducing the gene dosage of Gabra5 in the TS mice dose-dependently improved their searching strategy (i.e., it reduced their thigmotactic behavior) (ANOVA karyotype F (1,60) = 177.01, p < 0.001; genotype F (2,60) = 4.30, p = 0.18; karyotype × genotype F (2,60) = 1.99, p = 0.14). This effect was not found in the CO mice.
The enhancement in the spatial and procedural learning after reducing the gene dosage of Gabra5 is not due to motor or motivational effects since no significant differences were found between the six groups of animals in the latency to reach the platform during the cued sessions (ANOVA karyotype F ( Table 2 ), motor coordination in the Rotarod ( Supplementary  Fig. 1 ) or the weight of animals that carry different numbers of copies of this gene ( Supplementary Fig. 4 ).
In addition, the improvements in cognitive abilities found in TS animals homozygous or heterozygous for the Gabra5 gene are not likely to be due to an amelioration of their attentional deficits because the hyperactivity of these animals was Supplementary Fig. 2 ), plus maze ( Supplementary Fig. 3 ) or hole board tests (Supplementary Table 3 ).
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Conditioned Fear
The TS mice showed a deficit in their ability to remember the association between a tone and an aversive stimulus. While these animals presented a larger number of freezing episodes (ANOVA karyotype F (1,60) = 5.70, p = 0.020; Fig. 2c ), these episodes were of a shorter duration (F (1,60) = 7.13, p = 0.010; Fig. 2d) , which is considered the most relevant index reflecting the memory of the association between the conditioned stimulus (the tone) and the unconditioned stimulus (the electric shock). The Gabra5 gene dosage did not exert any effect on the number of freezing episodes (ANOVA genotype F (2,60) = 1.23, p = 0.29; karyotype × genotype F (2,60) = 2.00, p = 0.14) or the time spent freezing (ANOVA genotype F (2,60) = 0.14, p = 0.86; karyotype × genotype F (2,60) = 3.13, p = 0.51) in the TS or CO mice.
During the context conditioning session, the TS mice displayed a marked difficulty in remembering the association between the context and the aversive stimulus. Although the statistical analysis revealed that the number of freezing episodes did not differ significantly between the TS and CO mice (ANOVA karyotype F (1,60) = 0.98; p = 0.32; Fig. 2c ), this effect was likely due to the marked increase in these episodes in the TS +/− and TS +/+ mice. In addition, the post hoc analysis revealed that the TS +/+ mice displayed a much smaller number of these episodes than the CO +/+ mice (p < 0.001). The TS mice also spent a shorter amount of time freezing during this session than the CO mice (ANOVA karyotype F ( 1 , 6 0 ) = 7.88; p = 0.007; Fig. 2d ). The deficit in the context fear conditioning completely disappeared in the TS +/− and TS −/− mice because these two groups of animals increased the number of freezing episodes (ANOVA genotype F (2,60) = 5.86, p = 0.005) and spent more time freezing (F (2,60) = 7.69, p = 0.001) than the TS +/+ mice. In fact, the heterozygous and homozygous TS mice did not differ from the CO mice with the three genotypes in any of these variables (Fig. 2c, d ). Despite the effect of the genetic manipulation in the TS animals, reducing one or both functional copies of the Gabra5 gene in the CO mice did not exert any benefit in the context conditioning (ANOVA karyotype × genotype: freezing episodes, F (2,60) = 9.29, p < 0.001; time freezing F (2,60) = 4.21, p = 0.020).
Differences in the anxiety displayed by these animals are not likely to play a role in these effects, as no differences were found in the motor or cognitive components of anxiety in the six groups of animals in the plus maze ( Supplementary Fig. 2 ) or open field ( Supplementary Fig. 3 ) tests. Fig. 3) .
Putative Mechanisms Implicated in the Changes
However, the TS +/− mice displayed fewer GABA A α5 receptors than the CO +/− mice in all structures (BANOVA karyotype × genotype^: anterior CA1 F (2,37) = 6.46, p = 0.005; anterior CA3 F (2,37) = 6.31, p = 0.005; anterior DG F (2,37) = 3.68, p = 0.038; posterior CA1 F (2,37) = 4.96, p = 0.014; anterior Hc F (2,37) = 9.16, p = 0.001; mean of all structures F (2,37) = 8.86, p = 0.001). These results may be due to an interaction between the Gabra5 gene and other genes or gene products that are overexpressed in the TS mice.
Reducing the number of functional copies of the Gabra5 gene dose-dependently lowered the number of GABA A α5 receptors in both the TS and CO mice (BANOVA genotype^: CA1 F (2,37) = 190.29, p < 0.001; anterior CA3 F (2,37) = 54.72, p < 0.001; anterior DG F (2,37) = 81.93, p < 0.001; posterior CA1 F (2,37) = 54.34, p < 0.001; anterior Hc F (2,37) = 167.34, p < 0.001; mean of all structures F (2,37) = 144.73, p < 0.001). This effect was particularly evident in the anterior CA1 area (Fig. 3) .
Changes in Inhibitory-Excitatory Balance: Density of GABAergic Synapse Markers (VGAT Immunofluorescence)
As previously described by several groups, the TS mice displayed an increased area occupied by a marker of GABAergic synapses VGAT (ANOVA karyotype F (1,30) = 4.70, p = 0.037; Fig. 4 ). Reducing the number of functional copies of the Gabra5 gene in the TS and CO mice dose-dependently reduced the area occupied by the VGAT+ boutons (ANOVA genotype F (2,30) = 13.82, p < 0.001); however, this effect was more evident in the TS than that in the CO mice (karyotype × genotype F (2,30) = 3.63, p = 0.037).
Neurogenesis: Cell Proliferation, Differentiation, and Survival
Cell Proliferation in the SGZ of the DG (Ki67 Immunofluorescence) The TS mice displayed a reduced number of proliferating cells in the SGZ of the hippocampus (ANOVA karyotype F (1,30) = 21.10, p < 0.001; Fig. 5 ). The reduction in the number of copies of the Gabra5 gene tended to increase the density of Ki67+ cells in the TS, but not in CO, mice; however, this effect did not reach statistical significance (ANOVA genotype F (2,30) = 0.36, p = 0.70; karyotype × genotype F (2,30) = 1.35; p = 0.27). Therefore, this effect is unlikely to account for the improvements in the cognitive performance in the two learning and memory tests described above that were found in the TS mice with a reduced Gabra5 gene dosage.
N e u r o n a l D i f f e r e n t i a t i o n ( D C X a n d C L R
Immunofluorescence) The TS mice presented a lower density of cells during the initial stages of differentiation (DCX+/ CLR− cells: ANOVA karyotype F (1,30) = 14.23, p = 0.001; Fig. 6 ). In the later stages (DCX+/CLR+), the density of this population did not significantly differ between the TS and CO mice when all genotypes were considered (ANOVA karyotype F (1,30) = 2.21, p = 0.14), which was likely due to the increased density found in the heterozygous and homozygous TS animals. However, the post hoc analysis revealed that the TS +/+ mice presented a lower density of DCX+/CLR+ cells than the CO +/+ mice. Reducing one or both copies of the Gabra5 gene significantly increased the density of both populations of immature cells in the TS and CO mice (ANOVA Fig. 6 ). These results suggest that reducing the function of the Gabra5 gene accelerates or increases the maturation of newly born cells.
Granule Cell Counts (DAPI)
The density of mature cells in the GCL of the hippocampus was reduced in the TS mice (ANOVA karyotype F (1,30) = 55.08, p < 0.001; Fig. 7) . However, the ANOVA revealed a non-significant effect of genotype in the TS or CO mice (genotype F (2,30) = 1.65, p = 0.20; karyotype × genotype F (2,30) = 1.67, p = 0.20); the post hoc comparisons between the TS animals with two copies of the Gabra5 gene and those with one or no functional copy of this gene revealed that reducing its dosage leads to a significant increase in the number of DAPI+ cells in the TS, but not in the CO, mice.
Synaptic Plasticity: Long-Term Potentiation Figure 8 shows that the induction of LTP was reduced in the TS mice compared with that in the CO mice (ANOVA karyotype F (1,25) = 4.11, p = 0.049). This effect was not too strong due to the positive effect of reducing the number of copies of the Gabra5 gene in the TS animals (see below). However, when the TS +/+ mice were compared with the CO +/+ mice, the former presented a stronger reduction in LTP (ANOVA karyotype F (1,25) = 12.65, p = 0.002).
When all groups were analyzed together, the RM MANOVA revealed that the genetic manipulation had no significant effect in the TS or CO mice (ANOVA genotype F (2,25) = 2.29, p = 0.11), and this result was due to the positive outcome in the LTP induction after reducing the Gabra5 gene dosage in the TS, but not the CO, mice (ANOVA karyotype × genotype F (2,25) = 4.38, p = 0.043; Fig. 8 ).
The groups of CO mice carrying two, one, or no functional copies of the Gabra5 gene did not differ in the amount of LTP generated after TBS (BANOVA^genotype 
Discussion
This study shows that genetically reducing the GABA A α5 -mediated inhibition ameliorated the cognitive deficits in TS mice. This genetic approach confirms previous findings regarding the role of the GABA-mediated inhibition in the cognitive deficits in TS mice and the procognitive effects of reducing this inhibition by targeting the GABA A α5 receptors. We characterized the behavioral, cognitive and neuromorphological effects of reducing the dosage of the Gabra5 gene in trisomic mice and their euploid littermates.
In agreement with previous studies [66, 67] , TS mice exhibited reduced viability with respect to CO mice. Although statistical analysis revealed no significant deviation from the expected Mendelian distribution in the percentage of animals with different dosages of the Gabra5 gene that were born, the extremely low viability of TS −/− animals (3%) suggests that this genetic manipulation might affect the viability of trisomic mice. An explanation for this finding could be that the interaction of Gabra5 with other triplicated genes aggravated the cardiovascular dysfunctions displayed by a larger number of TS mice that reduce their perinatal survival. Previous work has shown that knocking out the Gabra5 gene in wild-type mice improved their performance in different hippocampal-dependent tasks [18, 19] . In the TS mice, modifying the number of functional copies of the Gabra5 gene attenuated the well-known spatial learning and memory impairments found in the MWM. This effect was also evident in the CO mice, although it was much more pronounced in the trisomic mice likely because of the larger impairment found in these animals and/or a floor effect in the CO mice. The improvements in performance in the MWM were not due to improvements in motivation or motor abilities since no significant differences were found in the latency to reach the platform during the cued trials or the animals' swimming speed. These effects are consistent with the lack of an effect of the Gabra5 gene dosage on motor coordination in mice of either karyotype as described in the Supplementary Results section.
In the case of the TS mice, the enhancement in the procedural learning may have played an important role in the procognitive effects found in the MWM because the heterozygous and homozygous Gabra5 TS mice presented less thigmotactic behavior.
Additionally, in the fear conditioning test, the TS mice showed impairments in both the cued and context conditioning. The reduction in the Gabra5 gene dosage completely rescued the context conditioning in the TS mice but did not have any effect on the cued conditioning. In rodents, the GABA A α5 receptors are mainly located in the hippocampus [10] [11] [12] [13] , and context conditioning is known to rely on the proper functioning of this structure, while the amygdala and other structures mediate cued conditioning [68, 69] , which may explain these results. Studies performed in Gabra5 KO mice in which their performance in hippocampal-independent tasks, such as delay fear conditioning and two-way avoidance, was unaltered [18] [19] [20] [21] further support this hypothesis.
The enhancements in the cognitive performance of the heterozygous and homozygous TS and CO mice in the MWM and in the TS animals in the fear conditioning test are likely due to a reduction in the GABA A α5 receptor-mediated inhibition.
However, reducing the Gabra5 gene dosage in TS animals only partially ameliorated their cognitive deficits. In the MWM test, the rescue of the cognitively altered phenotype was not complete and might have been mainly mediated by decreased thigmotaxis. In the fear conditioning test, normalization of performance was only achieved in the contextual memory test after reducing the Gabra5 gene dosage, but this genetic manipulation did not have any effect on the memory abilities displayed by the different groups of TS mice in the cued conditioning test. Moreover, as shown in the Supplementary Material, reducing GABA A α5 receptor expression did not rescue the hyperactivity or the motor coordination deficits of TS animals. Therefore, reduction of GABA A α5 receptor-mediated inhibition only partially improved specific cognitive domains (i.e., hippocampal-dependent spatial learning and context conditioning).
Our autoradiographic results confirmed that reducing the number of functional copies of the Gabra5 gene dosedependently lowered the density of GABA A α5 receptors in mice with both genotypes. However, the effect of removing a single copy of Gabra5 was larger in the TS +/− mice than that in the CO +/− mice in all structures analyzed. These results may be due to an interaction between the Gabra5 gene and other genes or gene products that are overexpressed in the TS mice. The greater reduction in the density of this type of receptor in the TS +/− mice than that in the CO +/− animals may be partially responsible for the greater cognitive benefits observed after knocking out this gene in the trisomic mice compared with those in the control mice. The density of the GABA A α5 receptors in the TS +/+ mice was similar to that in the CO +/+ mice. These results are consistent with other studies that showed that the TS and CO mice do not differ in the number of GABA A α5 receptors [45, 70] and with the fact that the Gabra5 gene is located in MMU7, and its orthologous human gene is located in HSA15; thus, this gene is not triplicated in the TS mouse or DS individuals. Therefore, the impairments in the neuronal plasticity and related cognitive problems in the TS mice cannot be attributed to the numbers of these receptors. However, it is possible that the enhanced GABA release in the hippocampus in TS mice results in a higher activity of these and other GABA A receptor subtypes.
Altogether, these results suggest that although the density of this type of receptor is not responsible for the altered learning abilities in the TS animals, manipulations that reduce the impaired GABA A -mediated inhibition in these mice have procognitive effects. In fact, several studies have demonstrated the procognitive effects of the administration of different α5 selective and non-selective NAMs in this model of DS [for a review, see 40] . Pharmacologically modulating the GABA A α5 receptors with different NAMs improved spatial learning and memory and reduced the thigmotactic behavior, thereby improving navigation strategies [44, 45] .
The smaller beneficial effect of knocking out Gabra5 on the cognitive abilities in the CO mice compared with that in the TS mice described in this study is consistent with a study by Ballard et al. [25] , who did not find improvement in working memory in control rats in the DMTP task or the MWM after a chronic RO4938581 treatment. Additionally, the NAM α5IA did not improve the cognitive performance of CO animals during the acquisition sessions in the MWM [37] . In contrast, RO4938581 improved the performance of unimpaired monkeys in the object retrieval task. These animals were exposed to the task infrequently to prevent asymptotic performance, thus allowing a window for improvement [25] . It is also possible that the precognitive effects of reducing GABA A α5 activity, genetically or pharmacologically, are more evident in those animals that have altered inhibition than in those that have an adequate balance between inhibitory and excitatory circuit influences.
In the present study, the TS +/+ mice presented an enhanced density of the area occupied by a marker of GABAergic synaptic boutons, VGAT, in the DG IML. Although several studies have shown that TS mice display impaired neuronal plasticity that is partially due to altered GABAergic signaling [36] [37] [38] [39] [40] [41] 71] , the imbalance between excitatory and inhibitory activity is not uniform in the trisomic brain. An increase in GABA A -mediated transmission has been found in the DG of TS mice [36, 71] but not in the CA3 [72, 73] or CA1 [74, 75] hippocampal subfields, and tonic GABAergic inhibition is less efficient in the cerebellum of TS mice [76] .
In addition, studies evaluating GABAergic synaptic density in different areas of the TS brain suggest that the number of these synapses is differentially affected depending on the brain region analyzed. Electron microscopy studies in the temporal cortex and hippocampus of adult TS mice found a normal density of symmetric (inhibitory) synapses [77] [78] [79] . Similarly, immunohistochemical evaluation of GABAergic terminals confirmed normal density in the TS mouse DG. In contrast, an increased GABAergic synaptic density was found in the IML, granular layer, and DG of TS mice [38, 45, 80] . The reasons for these discrepancies are not fully understood, but compensatory mechanisms after altered brain development occurs might account for these regional changes.
The changes in the area occupied by VGAT+ boutons found in the present study and in previous studies [45, 80] are likely to be restricted to the area analyzed, and cannot be considered a generalized modification of synaptic inhibition. Future studies should also evaluate the effect of modifying GABA A α5 function and/or expression on GABAergic synaptic markers in other hippocampal areas.
Recently it has been proposed that GABA might be excitatory rather than inhibitory in TS mice challenging the wellestablished concept of excessive GABA-mediated inhibition underlying cognition impairment in this mouse model of DS [81] . However, these data remains to be reproduced.
Other murine models of DS with different sets of triplicated genes display excitatory-inhibitory balance anomalies similar to those found in TS mice. The Ts1Cje mouse presents abnormalities in the morphology of inhibitory synapses in the hippocampus and cortex [79, 82, 83] . The Dp16 model exhibits an increase in the expression in the cortex and hippocampus of the GAD67 and VGAT proteins, implicated in inhibitory transmission [84] . These results suggest that the overexpression of one or several of the genes triplicated in the three models could be responsible for the altered inhibition found in DS mouse models. Among these, the Synj1 [85] , Olig1 and Olig2 [74] , and the Dyrk1A [80, 84] gene have been proposed to play a role in the excitatory/inhibitory imbalance found in trisomic animals.
In the heterozygous TS +/− mice, the density of VGAT+ boutons was completely normalized, and this effect was more pronounced in the TS −/− mice. In the CO mice, the reduction in the number of functional copies of the Gabra5 gene also dose-dependently reduced the area that was occupied by VGAT+ boutons. This reduction in the inhibitory influence of GABAergic synapses could be one of the mechanisms underlying the cognitive enhancement found in mice of both karyotypes in the MWM and the fear conditioning test in the TS mice. Martínez-Cué et al. [45] also demonstrated that a chronic administration of a α5 selective NAM reduced the area that was occupied by VGAT+ boutons in TS animals, thereby reducing the overinhibition.
Previous studies in Gabra5 KO mice suggested that the absence of α5 subunit is not compensated by an upregulation of α1, α2, or α3 subunits and that the pharmacology of hippocampal benzodiazepine sites remaining was unchanged [18] . Our data does not exclude that reduction of α5 subunits did not induce compensatory effects in TS mice but restoration of LTP in this mouse is in line with the role of this receptor subtype in controlling synaptic plasticity. Reduction of extrasynaptic GABA A α5 receptors in TS mice may have also impacted on the density and/or properties of their GABAergic synapses. It has been demonstrated that alterations in receptor assembly or subunit expression levels can indirectly alter synaptic localization and function [86] . In addition, tonic GABA Amediated membrane depolarization has been shown to promote synapse formation [87] .
Because GABA A receptors regulate the proliferation, migration, differentiation, and integration of new neurons [88] [89] [90] [91] [92] , the decrease in the GABA A mediated-inhibition in the TS mouse after knocking out the Gabra5 gene could play a role in the procognitive effects found in the TS animals by reducing functional and/or neuromorphological anomalies in their hippocampi. Tonic depolarizing GABA A responses by GABAergic Parvalbumin interneurons negatively regulate adult neurogenesis in the DG of the hippocampus [93] [94] [95] .
Although the present neuromorphological studies showed a tendency in which the density of proliferating (Ki67+) cells in the hippocampi of TS +/− and TS −/− mice was increased, this tendency did not reach statistical significance. Therefore, this effect is unlikely to account for the improvements in cognitive performance found in the heterozygous and homozygous TS mice. However, the reduced density of cells during late mitotic and early postmitotic stages (DCX+/CLR− cells) and during late postmitotic stages (DCX+/CLR+ cells) in the TS +/+ mice was completely rescued after knocking out both copies of the Gabra5 gene, which suggests that reducing the function of this gene accelerates or increases the maturation of newly born cells. When the density of the mature granule cells in the GCL of the hippocampus was evaluated, it was found that reducing the dosage of the Gabra5 gene led to a significant increase in the number of DAPI+ cells in the TS, but not in the CO, mice, which could also play a role in the described cognitive enhancing effects. Proliferating, immature neurons in different stages of differentiation and mature granule cells appear to have different electrophysiological properties and roles in learning and memory processes [95] [96] [97] [98] [99] . Therefore, the enhanced maturation of newly born cells that were found after reducing the Gabra5 gene dosage in this study may be one of the mechanisms responsible for the enhancement in cognition that was induced by this genetic manipulation. However, the present results are not entirely consistent with our previous results in which after the chronic administration of RO4938581 to TS mice, a complete rescue of proliferating and mature cells was found, although the effect of this compound on the differentiating cells was not evaluated [45] . Therefore, the mechanisms by which the pharmacological and genetic reduction of the overinhibition in TS mice induce the procognitive effects appear to be slightly different. Another explanation is that the genetic approach may lead to an adaptation or compensatory changes early in development, which is less visible in adulthood.
There are numerous reports of the role of adult hippocampal neurogenesis in the establishment of LTP and in learning and memory processes [100-103]; therefore, enhancing neurogenesis could enhance LTP and the cognitive abilities of TS mice. In agreement with numerous reports demonstrating that LTP is altered in the hippocampal CA1/CA3 and DG regions in TS mice due to altered GABA-mediated activity [36, 37, 41, 82] , the present study also showed a deteriorated LTP in the CA1/CA3 region of TS +/+ animals.
A comparative evaluation of synaptic plasticity deficits in other DS mouse models has shown that LTP in the CA3/CA1 region was decreased in Ts1Cje, Dp16 and triple trisomic mice (Dp10/Dp16/Dp17), unchanged in Ts1Rhr and Dp10 mice, and even significantly increased in Dp17 mice [104] [105] [106] [107] . In the DG, LTP was impaired in Ts1Cje, Ts1Rhr, and triple trisomic (Dp10/Dp16/Dp17) mice [82, 108] . Because Dp16 and triple trisomic mice (Dp10/Dp16/Dp17) show behavioral and synaptic plasticity deficits comparable to those found in TS mice [106] [107] [108] , and Dp10 and Dp17 mice show normal (or even enhanced) performances [107] , it is possible that the set of MMU16 syntenic genes overexpressed in TS and in Dp16 mice plays an important role in this altered synaptic plasticity.
In the present study, the impairment to LTP presented by TS +/+ mice was completely rescued after reducing the Gabra5 gene dosage. The GABA A α5 subunit-containing receptors are predominantly localized extrasynaptically in the dendrites of hippocampal CA1 pyramidal neurons [10] [11] [12] [13] and generate long-lasting tonic currents [14] [15] [16] [17] . However, these receptors have also been detected at GABAergic synapses on the same dendrites of hippocampal pyramidal neurons and could, therefore, mediate phasic GABAergic inhibition as well [65] . Because tonic currents drive neuronal migration and maturation, axon growth, and synaptic plasticity [109] [110] [111] [112] , the reduction of the density of GABA A α5 subunit-containing receptors in heterozygous or homozygous Gabra5 TS mice could be a mechanism partially responsible for the observed improvements in neurogenesis and LTP, thereby enhancing cognition in these animals.
However, reducing the number of functional copies of the Gabra5 gene did not have any significant effect on LTP in the CO mice, which is consistent with other studies that failed to find changes in LTP in Gabra5 KO mice [18, 20] , except for under certain stimulation conditions [19] .
The differential effects of reducing the number of copies of the Gabra5 gene in the TS and CO mice on LTP may be one of the mechanisms implicated in the improved cognition that is found in the TS mice but is not as evident in the CO mice in the MWM and was absent in the fear conditioning test. These results are consistent with the normalization of LTP displayed by the TS animals after a chronic administration of RO4938581 without a significant effect in the CO animals [45] . However, other authors have reported that the chronic administration of α5IA or RO4938581 increases hippocampal LTP in normal rodents [25, 113] . As mentioned above, the discrepancies between the results of these reports and the present study may be due to the different backgrounds of the CO mice.
Finally, the TS and CO animals that differently expressed the Gabra5 gene did not show alterations in anxiety or motor abilities (see Supplementary Results and Discussion). These results provide further support for the selectivity of the α5 receptor in cognitive functions and its role as a therapeutic target for learning and memory altered states.
In summary, this study shows that reducing the number of functional copies of the Gabra5 gene in TS mice had effects that were similar to those observed following the chronic administration of an α5-selective NAM as follows: it induced a partial procognitive effect, improved LTP, enhanced neural differentiation and maturation, and normalized the density of the GABAergic synapse markers. These effects were gene dose-dependent and were more evident in the TS mice than in the CO mice. In addition, modifying the gene dosage of Gabra5 did not induce motor alterations and anxiety or reduced the viability of the mice. Although the present work and the results from pharmacological studies support that reducing the GABA A mediated-inhibition is a good target for improving cognitive alterations in DS, the fact that all these studies have been performed in animal models of DS limit their translational value to the human condition. Thus far, there is no confirmation that there is an enhanced inhibition in the brains of individuals with DS. Thus, studies in humans are necessary to demonstrate the potential translational value of these findings.
